Serial Number:
76226598
Mark:
IPO IMPATH PREDICTIVE ONCOLOGY
Status:
Cancelled-Section 8
Status Date:
02-06-2010
Filing Date:
Registration Number:
2731185
Registration Date:
07-01-2003
Biopharmacogenomic services, namely research and development in targeted drug and diagnostic product discovery, drug development and diagnostic product and targeted therapies for others
Mark Description:
The mark consists of the stylized letters "IPO".
Class:
Scientific and technological services
Type of Mark:
Servicemark
Published for Opposition Date:
04-08-2003
Owner:
Mark Drawing Status:
Design plus Words, Letters, and/or Numbers
Abandon Date:
N/A
Business Name:
GENZYME CORPORATION
Correspondent Name:
